Condition

Corona Virus Infection (3)

Acute Respiratory Distress Syndrome (1)

Coronavirus (1)

Coronavirus Infections (1)

SARS-CoV Infection (1)

Overall Status

Completed (2)

Terminated (1)

Phase

phase 3 (3)

Sponsor

Montreal Heart Institute (1)

Sanofi (1)

University of Minnesota (1)

Collaborator

Bill and Melinda Gates Foundation (1)

DACIMA Software (1)

McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Regeneron Pharmaceuticals (1)

The Government of Quebec (1)

University of Alberta (1)

University of Manitoba (1)

Intervention

placebo (2)

colchicine (1)

hydroxychloroquine (1)

placebo oral tablet (1)

sarilumab sar153191 (1)

Study Documents

Individual Participant Data Set (1)

Intervention Type

drug (3)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

Corona Virus Infection

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Corona Virus Infection Trial in Worldwide (Sarilumab SAR153191, Placebo)

Completed

Has Results

Corona Virus Infection

Sarilumab SAR153191
Placebo

Caba, Argentina
+46 more

Mar 15, 2022

Corona Virus Infection Trial in Worldwide (Colchicine, Placebo oral tablet)

Terminated

Has Results

Corona Virus Infection

Colchicine
Placebo oral tablet

Phoenix, Arizona
+31 more

Sep 3, 2021

Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection Trial in Canada, United States

Completed

Has Results

Corona Virus Infection
+4 more

Hydroxychloroquine
Placebo

Minneapolis, Minnesota
+4 more

May 11, 2021